Back
Splash Beverage Group Vs. Cidara Therapeutics Industry Stock Comparison
Sell
26
SBEV
Splash Beverage Group
Last Price:
$1.55
Seasonality Move:
-7.47%
Buy
80
CDTX
Cidara Therapeutics
Last Price:
$65.20
Seasonality Move:
2.23%
Sell
26
Splash Beverage Group (SBEV)
is a Sell
Is Splash Beverage Group a Buy, Sell or Hold?
-
The current Splash Beverage Group [SBEV] share price is $1.58. The Score for SBEV is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
SBEV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $65.22. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SBEV Stock Price Chart
What is Splash Beverage Group's stock price today?
-
The Splash Beverage Group share price today is $1.58The current trend is moderately bullish and SBEV is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $65.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SBEV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 34.89 | Sell |
Chaikin Money Flow: | -4555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.59 - 2.61) | Sell |
Bollinger Bands (100): | (1.75 - 5.15) | Sell |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.52 | Buy |
Relative Strength Index (14 RSI): | 72.5 | Buy |
Chaikin Money Flow: | 325218 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.36 - 64.38) | Buy |
Bollinger Bands (100): | (17.47 - 52.87) | Buy |
SBEV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.7 | Sell |
20-day SMA: | 1.88 | Sell |
50-day SMA: | 2.7 | Sell |
200-day SMA: | 5.25 | Sell |
8-day EMA: | 1.64 | Sell |
20-day EMA: | 1.31 | Buy |
50-day EMA: | 0.76 | Buy |
200-day EMA: | 0.23 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.72 | Buy |
20-day SMA: | 62.33 | Buy |
50-day SMA: | 49.33 | Buy |
200-day SMA: | 27.87 | Buy |
8-day EMA: | 61.33 | Buy |
20-day EMA: | 47.32 | Buy |
50-day EMA: | 26.86 | Buy |
200-day EMA: | 8.18 | Buy |
Splash Beverage Group Earnings Growth & SBEV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.60 per share, and a decrease next year of $0.80 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.
Splash Beverage Group Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |